Annual Cash & Cash Equivalents
$30.56 M
+$10.78 M+54.46%
December 31, 2023
Summary
- As of February 7, 2025, OBIO annual cash & cash equivalents is $30.56 million, with the most recent change of +$10.78 million (+54.46%) on December 31, 2023.
- During the last 3 years, OBIO annual cash & cash equivalents has risen by +$10.22 million (+50.22%).
- OBIO annual cash & cash equivalents is now at all-time high.
Performance
OBIO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$25.61 M
+$1.89 M+7.98%
September 30, 2024
Summary
- As of February 7, 2025, OBIO quarterly cash and cash equivalents is $25.61 million, with the most recent change of +$1.89 million (+7.98%) on September 30, 2024.
- Over the past year, OBIO quarterly cash and cash equivalents has increased by +$6.53 million (+34.21%).
- OBIO quarterly cash and cash equivalents is now -76.06% below its all-time high of $106.97 million, reached on June 30, 2022.
Performance
OBIO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
OBIO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.5% | +34.2% |
| 3 y3 years | +50.2% | +29.4% |
| 5 y5 years | +50.2% | +29.4% |
OBIO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +207.5% | -76.1% | +157.7% |
| 5 y | 5-year | at high | +207.5% | -76.1% | +157.7% |
| alltime | all time | at high | +207.5% | -76.1% | +157.7% |
Orchestra BioMed Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $25.61 M(+8.0%) |
| Jun 2024 | - | $23.71 M(+1.7%) |
| Mar 2024 | - | $23.32 M(-23.7%) |
| Dec 2023 | $30.56 M | $30.56 M(+60.2%) |
| Sep 2023 | - | $19.08 M(+16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $16.41 M(-12.2%) |
| Mar 2023 | - | $18.70 M(-5.5%) |
| Dec 2022 | $19.78 M(+99.1%) | $19.78 M(-81.5%) |
| Jun 2022 | - | $106.97 M(+976.4%) |
| Dec 2021 | $9.94 M(-51.1%) | $9.94 M |
| Dec 2020 | $20.34 M | - |
FAQ
- What is Orchestra BioMed Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings annual cash & cash equivalents year-on-year change?
- What is Orchestra BioMed Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings quarterly cash and cash equivalents year-on-year change?
What is Orchestra BioMed Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of OBIO is $30.56 M
What is the all time high annual cash & cash equivalents for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high annual cash & cash equivalents is $30.56 M
What is Orchestra BioMed Holdings annual cash & cash equivalents year-on-year change?
Over the past year, OBIO annual cash & cash equivalents has changed by +$10.78 M (+54.46%)
What is Orchestra BioMed Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OBIO is $25.61 M
What is the all time high quarterly cash and cash equivalents for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high quarterly cash and cash equivalents is $106.97 M
What is Orchestra BioMed Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, OBIO quarterly cash and cash equivalents has changed by +$6.53 M (+34.21%)